Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Return on Equity (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Return on Equity for 4 consecutive years, with 0.51% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 100.0% to 0.51% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.51% through Dec 2025, down 100.0% year-over-year, with the annual reading at 0.64% for FY2025, 141.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.51% at Phathom Pharmaceuticals, down from 0.66% in the prior quarter.
  • The five-year high for Return on Equity was 2043.99% in Q3 2023, with the low at 0.51% in Q4 2025.
  • Average Return on Equity over 4 years is 159.23%, with a median of 1.61% recorded in 2024.
  • The sharpest move saw Return on Equity skyrocketed 55bps in 2023, then plummeted -204238bps in 2024.
  • Over 4 years, Return on Equity stood at 3.9% in 2022, then rose by 14bps to 4.45% in 2023, then crashed by -66bps to 1.52% in 2024, then tumbled by -66bps to 0.51% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.51%, 0.66%, and 0.89% for Q4 2025, Q3 2025, and Q2 2025 respectively.